Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
D000243:Adenosine Deaminase / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism; D001089:Arabinose / Q000031:analogs & derivatives / Q000378:metabolism; D001667:Binding, Competitive; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D003839:Deoxyadenosines / Q000494:pharmacology; D008223:Lymphoma / Q000188:drug therapy / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D019384:Nucleic Acid Synthesis Inhibitors; D014740:Vidarabine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*
D004273:DNA, Neoplasm; D003839:Deoxyadenosines; D019384:Nucleic Acid Synthesis Inhibitors; D000255:Adenosine Triphosphate; D001089:Arabinose; D012321:DNA-Directed RNA Polymerases; D000243:Adenosine Deaminase; D014740:Vidarabine